James Koziarz

Dr. Koziarz was President and CEO of Rubicon Genomics, a leader in the commercialization of preanalytical processes to improve the performance and capabilities of analytical platforms for research and clinical testing. The company was sold to Takara Bio in 2017. Previously he worked for 25 years in the Diagnostics Division of Abbott Laboratories, including 11 years as a corporate officer where he managed groups involved in product development, manufacturing and customer technical support, and new technology management. Since retirement from Abbott, he has been an active member of the entrepreneurial and venture communities, serving as an advisor to PhysIQ and several early stage, venture-backed life sciences companies. Prior to joining Abbott in 1979, Jim was a postdoctoral fellow in biochemistry at the University of Chicago. He earned a B.S. in chemistry from DePaul University, a Ph.D. in biochemistry from the University of Chicago, and won a National Research Service Award as a postdoctoral fellow.